New blood and cell ther­a­py-fo­cused ven­ture fund emerges with $50M and a Jen­nifer Doud­na spin­out in tow

A $50 mil­lion ven­ture fund ded­i­cat­ed to blood-re­lat­ed fields and cell ther­a­pies emerged Thurs­day af­ter spend­ing about a year build­ing out its ini­tial in­vest­ments in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER